None listed
Conditions
Brief summary
Dental plaque is a biofilm of microorganisms found on a tooth surface, embedded in a matrix of polymers of host and bacterial origin. The presence of dental plaque can provoke gingivitis and periodontitis. This work aims to evaluate the non-inferiority of two different mouthrinses, one synthetic and one natural, respect on a mouthrinse gold standard as an aid for home oral hygiene.
Interventions
The following mouthrinses will be evaluated: -Group A: containing Propolis resin extract (1:3), Plantago lanceolata leaves extract (1:10), Salvia officinalis leaves extract (1:1) and 1.75% of essential oils from Salvia officinalis, Syzygium aromaticum buds, Mentha piperita leaves, Commiphora myrrha oleoresin and Pistacia lentiscus oleoresin (Fitomedical snc, Binasco, Milan, Italy). - Group B: containing 0,09% of chlorhexidine (CHX) and CITROX® (formulation deriving from the extract of bitter orange peel) (Curaprox Italia S.r.l. , Bolzano, Italy). The patients will use the assigned mouthrinses twice a day for two weeks. At baseline a single examiner , with more than 8 years of practice, will collect the clinical parameters. All patients will receive a written instruction of the tested mouthrinses and their right dosage. The participants will be instructed to gargle 10 ml of the mouthrinse for a period of 60 seconds, after which the mouthrinse is spit out. Moreover, they will be instructed to not rinse/eat anything for 30 minutes after mouthrinse use. The patients will continue to perform their routine oral home care, adding only the assigned mouthrinse. Patient self-report diary will be use to monitor adherence of the patient to intervention.
Sponsors
Study design
Eligibility
Inclusion criteria
minimum of 20 teeth, good physical health, gingivitis, periodontitis stages I or II
Exclusion criteria
1) active caries 2) wearers of dentures and of orthodontic appliances; 3) severe malocclusion; 4) use of oral antiseptics in the previous three months; 5) subjects with medical disorders; 6) undergoing antibiotic or other antimicrobial therapy in the previous 3 months; 7) the presence of any systemic disease that could alter the production or composition of the saliva or dental plaque; 8) individuals with an allergy to any ingredients used in the study; 9) pregnant women.